Heartbeam Inc
NASDAQ:BEAT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Heartbeam Inc
NASDAQ:BEAT
|
US |
|
S
|
Selic Corp PCL
SET:SELIC
|
TH |
|
Manganese X Energy Corp
XTSX:MN
|
CA |
|
C
|
Cyfuse Biomedical KK
TSE:4892
|
JP |
|
Playfair Mining Ltd
XTSX:PLY
|
CA |
|
R
|
Rasan Information Technology Company SCJSC
SAU:8313
|
SA |
|
C
|
Capital Park SA
WSE:CPG
|
PL |
|
M
|
Metals Acquisition Ltd
ASX:MAC
|
JE |
|
Kibo Energy PLC
LSE:KIBO
|
IE |
|
Cholamandalam Financial Holdings Ltd
NSE:CHOLAHLDNG
|
IN |
Heartbeam Inc
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. The company is headquartered in Santa Clara, California and currently employs 5 full-time employees. The company went IPO on 2021-10-14. The company specializes in cardiovascular diagnostic technology. The company is primarily focused on telemedicine solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company focuses on providing diagnostic data to help physicians with care management of patients with cardiovascular disease. The company delivers remote diagnostic and monitoring technologies that can be used for patients anywhere for ambulatory and emergency room (ER) use. Its telehealth product is comprised of a credit card-sized Electrocardiogram (ECG) machine and a cloud-based diagnostic software system. The company is applying its platform technology to create a software tool for detecting heart attacks in the ED environment. This software tool is designed to enable emergency physicians to diagnose heart attacks. Its credit card sized cardiac electrical signal collection device captures cardiac signals that represent projections of the heart vector.
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. The company is headquartered in Santa Clara, California and currently employs 5 full-time employees. The company went IPO on 2021-10-14. The company specializes in cardiovascular diagnostic technology. The company is primarily focused on telemedicine solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company focuses on providing diagnostic data to help physicians with care management of patients with cardiovascular disease. The company delivers remote diagnostic and monitoring technologies that can be used for patients anywhere for ambulatory and emergency room (ER) use. Its telehealth product is comprised of a credit card-sized Electrocardiogram (ECG) machine and a cloud-based diagnostic software system. The company is applying its platform technology to create a software tool for detecting heart attacks in the ED environment. This software tool is designed to enable emergency physicians to diagnose heart attacks. Its credit card sized cardiac electrical signal collection device captures cardiac signals that represent projections of the heart vector.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
